Tag: antiviral

Lenacapavir Shows Viral Suppression in Drug-Resistant HIV

Dr Jean-Michel Molina The long-acting drug lenacapavir, a first-in-class capsid inhibitor, shows sustained viral suppression in a small cohort of heavily treatment-experienced patients with multidrug-resistant...

Three New Drugs Implicated in ANCA-Associated Vasculitis

The overactive bladder treatment mirabegron (Myrbetriq) is one of three new drugs to be linked to cases of drug-associated antineutrophil cytoplasmic antibody–associated vasculitis (DA-AAV) according...

Large Remdesivir Study Finds No COVID-19 Survival Benefit

Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. A lack of consensus in the evidence regarding the antiviral remdesivir (Veklury) to...

Hepatitis C Antivirals May Fight SARS-CoV-2

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. An antiviral drug combination used to treat hepatitis C and an...

Pandemic Boosts Care for Serious Illnesses at Home

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Late last year, Janet Yetenekian was one of the thousands of...

First Pill for COVID-19 Could Be Ready by Year’s End

New pills to treat patients with COVID-19 are currently in midstage clinical trials and, if successful, could be ready by the end of the year....

Vaginal Ring Could Protect Women From HIV for 3 Months

TUESDAY, March 9, 2021 (HealthDay News) — A vaginal ring that slowly releases an antiviral medication could protect women against HIV for up to three...

Oral Antiviral Stops SARS-CoV-2 in its Tracks

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A single pill of the investigational drug molnupiravir taken twice a...

Black Doctor Dies of COVID After Alleging Subpar Treatment

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. “This is how Black people get killed.” These are some of...

FDA Says It Won’t Object to Dry Heat Use on N95 Respirators

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) says it will not...

Convalescent Plasma Falls Short in Phase 2 Trial

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Convalescent plasma may not prevent progression to severe disease or reduce...

FDA Approves Remdesivir, First Treatment for COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) approved remdesivir (Veklury) today...

Remdesivir Does Not Reduce COVID-19 Mortality, Study Says

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A large study sponsored by the World Health Organization found that...

Two Major COVID Trials Paused for Safety Issues

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. This story was updated Oct. 13, at 4:05 p.m. Oct. 13,...

Once-Weekly Investigational MK-8507 Potent Even at Low Doses

A single dose of MK-8507, an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), reduced HIV-1 viral loads for at least 1 week with efficacy comparable to...

Remdesivir Effective, Well-Tolerated in Final Trial Report

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A final report from the multinational placebo-controlled ACTT-1 trial confirms that...

Convalescent Blood Plasma Safe, Effective for COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Convalescent blood plasma is a useful and relatively safe therapy for...

Trio Awarded Nobel Prize in Medicine for Discovering Hep C Virus

The Nobel Prize in Physiology or Medicine was awarded to two Americans and a British-born scientist this morning for the discovery of the hepatitis C...

The Art and Science of Risk Communication

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Infectious disease expert Anthony Fauci. Coronavirus response coordinator Deborah Birx. County...

COVID-19 Update: Elusive Complication, Remdesivir Toxicity

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...

FDA OKs First-in-Class HIV Therapy for Patients With Few Options

The US Food and Drug Administration has approved fostemsavir (Rukobia, ViiV Healthcare), a first-in-class attachment inhibitor for the treatment of HIV-1 infection in adults. Fostemsavir...

Fauci Warns of 100K Cases/Day, HCQ Trial to Resume

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...

Antibodies Tested as Possible COVID Treatment

Indeed, when the Regeneron team screened single antibodies against the coronavirus, it found the virus could escape them fairly easily within just a few...

Prescription Fills Mostly Down for Leading Drugs

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Prescription fills for hydroxychloroquine/chloroquine spiked right after COVID-19 was declared a...

Fauci Testifies, HCQ Trials Lack ECG

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...